Showing 1 - 15 results of 15 for search 'Nathoo, K', query time: 0.04s
Refine Results
-
1
Chronic lung disease in HIV-infected children established on antiretroviral therapy by Rylance, J, Mchugh, G, Metcalfe, J, Mujuru, H, Nathoo, K, Wilmore, S, Rowland-Jones, S, Majonga, E, Kranzer, K, Ferrand, R
Published 2016Journal article -
2
Pubertal development in HIV-infected African children on first-line antiretroviral therapy. by Szubert, A, Musiime, V, Bwakura-Dangarembizi, M, Nahirya-Ntege, P, Kekitiinwa, A, Gibb, D, Nathoo, K, Prendergast, A, Walker, A
Published 2015Journal article -
3
Single-dose nevirapine exposure does not affect response to antiretroviral therapy in HIV-infected African children aged below 3 years. by Musoke, P, Szubert, A, Musiime, V, Nathoo, K, Nahirya-Ntege, P, Mutasa, K, Williams, D, Prendergast, A, Spyer, M, Walker, A, Gibb, D
Published 2015Journal article -
4
Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe. by Walker, A, Prendergast, A, Mugyenyi, P, Munderi, P, Hakim, J, Kekitiinwa, A, Katabira, E, Gilks, C, Kityo, C, Nahirya-Ntege, P, Nathoo, K, Gibb, D
Published 2012Journal article -
5
Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study. by Picat, M, Lewis, J, Musiime, V, Prendergast, A, Nathoo, K, Kekitiinwa, A, Nahirya Ntege, P, Gibb, D, Thiebaut, R, Walker, A, Klein, N, Callard, R
Published 2013Journal article -
6
Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy. by Bwakura-Dangarembizi, M, Musiime, V, Szubert, A, Prendergast, A, Gomo, Z, Thomason, M, Musarurwa, C, Mugyenyi, P, Nahirya, P, Kekitiinwa, A, Gibb, D, Walker, A, Nathoo, K
Published 2015Journal article -
7
Opportunities for improving the efficiency of paediatric HIV treatment programmes. by Revill, P, Walker, S, Mabugu, T, Nathoo, K, Mugyenyi, P, Kekitinwa, A, Munderi, P, Bwakura-Dangarembizi, M, Musiime, V, Bakeera-Kitaka, S, Nahirya-Ntege, P, Walker, A, Sculpher, M, Gibb, D
Published 2015Journal article -
8
Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial. by Gibb, D, Kizito, H, Russell, E, Chidziva, E, Zalwango, E, Nalumenya, R, Spyer, M, Tumukunde, D, Nathoo, K, Munderi, P, Kyomugisha, H, Hakim, J, Grosskurth, H, Gilks, C, Walker, A, Musoke, P
Published 2012Journal article -
9
A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa. by Bwakura-Dangarembizi, M, Kendall, L, Bakeera-Kitaka, S, Nahirya-Ntege, P, Keishanyu, R, Nathoo, K, Spyer, M, Kekitiinwa, A, Lutaakome, J, Mhute, T, Kasirye, P, Munderi, P, Musiime, V, Gibb, D, Walker, A, Prendergast, A
Published 2014Journal article -
10
Late presentation with HIV in Africa: phenotypes, risk and risk stratification in the REALITY trial by Siika, A, McCabe, L, Bwakura-Dangarembizi, M, Kityo, C, Mallewa, J, Berkley, J, Maitland, K, Griffiths, A, Baleeta, K, Mudzingwa, S, Abach, J, Nathoo, K, Thomason, M, Prendergast, A, Walker, A, Gibb, D
Published 2018Journal article -
11
Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy. by Crook, A, Turkova, A, Musiime, V, Bwakura-Dangarembizi, M, Bakeera-Kitaka, S, Nahirya-Ntege, P, Thomason, M, Mugyenyi, P, Musoke, P, Kekitiinwa, A, Munderi, P, Nathoo, K, Prendergast, A, Walker, A, Gibb, D, ARROW Trial Team
Published 2016Journal article -
12
Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factori... by Kekitiinwa, A, Cook, A, Nathoo, K, Mugyenyi, P, Nahirya-Ntege, P, Bakeera-Kitaka, S, Thomason, M, Bwakura-Dangarembizi, M, Musiime, V, Munderi, P, Naidoo-James, B, Vhembo, T, Tumusiime, C, Katuramu, R, Crawley, J, Prendergast, A, Musoke, P, Walker, A, Gibb, D
Published 2013Journal article -
13
Enhanced prophylaxis with antiretroviral therapy for advanced HIV in Africa by Hakim, J, Musiime, V, Szubert, A, Mallewa, J, Siika, A, Agutu, C, Walker, S, Pett, S, Bwakura-Dangarembizi, M, Lugemwa, A, Kaunda, S, Karoney, M, Musoro, G, Kabahenda, S, Nathoo, K, Maitland, K, Griffiths, A, Thomason, M, Kityo, C, Mugyenyi, P, Prendergast, A, Walker, A, Gibb, D
Published 2017Journal article -
14
Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial by Kityo, C, Szubert, A, Siika, A, Heydermann, R, Bwakura-Dangarembizi, M, Lugemwa, A, Mwaringa, S, Griffiths, A, Nkanya, I, Kabahenda, S, Wachira, S, Musoro, G, Rajapakse, C, Etyang, T, Abach, J, Spyer, M, Wavamunno, P, Nyondo-Mipanda, L, Chidziva, E, Nathoo, K, Klein, N, Hakim, J, Gibb, D, Walker, A, Pett, S
Published 2018Journal article -
15
Health outcomes, pathogenesis and epidemiology of severe acute malnutrition (HOPE-SAM): rationale and methods of a longitudinal observational study by Bwakura-Dangarembizi, M, Amadi, B, Bourke, C, Robertson, R, Mwapenya, B, Chandwe, K, Kapoma, C, Cifunda, K, Majo, F, Ngosa, D, Chakra, P, Chuku, N, Masimba, F, Mapurisa, I, Besa, E, Mutasa, K, Mwakamui, S, Runodamoto, T, Humphrey, J, Ntozini, R, Wells, J, Manges, A, Swann, J, Walker, A, Nathoo, K, Kelly, P, Prendergast, A
Published 2019Journal article